BC
BEAM icon

BIT Capital’s Beam Therapeutics BEAM Stock Holding History

BIT Capital’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,390
Closed -$82.3K – 113
2025
Q3 		$82.3K Sell
3,390
-213
-6% -$4.24K ﹤0.01% 91
2025
Q2 		$61.3K Sell
3,603
-12,168
-77% -$212K ﹤0.01% 84
2025
Q1 		$308K Sell
15,771
-19,643
-55% -$515K 0.03% 89
2024
Q4 		$878K Buy
+35,414
New +$904K 0.07% 76

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT Capital's BEAM Position: Q4 2025 in Review

BIT Capital sold out of Beam Therapeutics (BEAM) in Q4 2025, closing a stake of 3,390 shares — an estimated $82.3K sold.

BIT Capital first reported a position in BEAM in Q4 2024 and held it in 4 quarters. The position peaked at $878K in Q4 2024. 246 funds tracked by Wall St. Rank hold BEAM as of Q4 2025.

  • BIT Capital reported no remaining Beam Therapeutics position as of Q4 2025 after selling out during the quarter.
  • BIT Capital sold 3,390 Beam Therapeutics shares in Q4 2025, an estimated $82.3K.
  • BIT Capital first reported a position in Beam Therapeutics in Q4 2024 and held it in 4 quarters.
  • BIT Capital's Beam Therapeutics position peaked at $878K in Q4 2024.
  • 246 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2025.

Based on BIT Capital's 13F filing for Q4 2025, filed 11 Feb 2026.